Anita S. Chong to Immunosuppressive Agents
This is a "connection" page, showing publications Anita S. Chong has written about Immunosuppressive Agents.
Connection Strength
3.686
-
Tracing Donor-MHC Class II Reactive B cells in Mouse Cardiac Transplantation: Delayed CTLA4-Ig Treatment Prevents Memory Alloreactive B-Cell Generation. Transplantation. 2016 08; 100(8):1683-91.
Score: 0.390
-
Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipients. Transplantation. 2014 Apr 27; 97(8):846-53.
Score: 0.333
-
Concurrent antiviral and immunosuppressive activities of leflunomide in vivo. Am J Transplant. 2006 Jan; 6(1):69-75.
Score: 0.187
-
Efficacy of FK506, leflunomide, anti-CD4, and CTLA4IG treatments in rat to mouse pancreas xenograft transplantation. Transplant Proc. 2000 Aug; 32(5):1003-4.
Score: 0.129
-
Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Transplantation. 1999 Sep 27; 68(6):814-25.
Score: 0.121
-
Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology. 1999; 42(5-6):412-8.
Score: 0.115
-
In vitro and in vivo mechanisms of action of the antiproliferative and immunosuppressive agent, brequinar sodium. J Immunol. 1998 Jan 15; 160(2):846-53.
Score: 0.108
-
Modification of humoral responses by the combination of leflunomide and cyclosporine in Lewis rats transplanted with hamster hearts. Transplantation. 1997 Dec 27; 64(12):1650-7.
Score: 0.107
-
Evolving Approaches in the Identification of Allograft-Reactive T and B Cells in Mice and Humans. Transplantation. 2017 11; 101(11):2671-2681.
Score: 0.106
-
Control of lymphoproliferative and autoimmune disease in MRL-lpr/lpr mice by brequinar sodium: mechanisms of action. J Pharmacol Exp Ther. 1997 Nov; 283(2):869-75.
Score: 0.106
-
The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms. J Immunol. 1997 Jul 01; 159(1):22-7.
Score: 0.104
-
In vivo mechanism by which leflunomide controls lymphoproliferative and autoimmune disease in MRL/MpJ-lpr/lpr mice. J Immunol. 1997 Jul 01; 159(1):167-74.
Score: 0.104
-
Two activities of the immunosuppressive metabolite of leflunomide, A77 1726. Inhibition of pyrimidine nucleotide synthesis and protein tyrosine phosphorylation. Biochem Pharmacol. 1996 Aug 23; 52(4):527-34.
Score: 0.098
-
Delayed xenograft rejection in the concordant hamster heart into Lewis rat model. Transplantation. 1996 Jul 15; 62(1):90-6.
Score: 0.097
-
Complete control of humoral and cell-mediated xenoreactions with the combination of leflunomide and cyclosporine. Transplant Proc. 1996 Apr; 28(2):684.
Score: 0.095
-
Effects of leflunomide and other immunosuppressive agents on T cell proliferation in vitro. Transplantation. 1996 Jan 15; 61(1):140-5.
Score: 0.094
-
Inhibition of protein tyrosine phosphorylation in T cells by a novel immunosuppressive agent, leflunomide. J Biol Chem. 1995 May 26; 270(21):12398-403.
Score: 0.090
-
Memory B cells in transplantation. Transplantation. 2015 Jan; 99(1):21-8.
Score: 0.087
-
Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine. Transplantation. 1994 Apr 27; 57(8):1223-31.
Score: 0.083
-
Microbes and allogeneic transplantation. Transplantation. 2014 Jan 15; 97(1):5-11.
Score: 0.082
-
Enhancing pancreatic Beta-cell regeneration in vivo with pioglitazone and alogliptin. PLoS One. 2013; 8(6):e65777.
Score: 0.078
-
Leflunomide, a novel immunosuppressive agent. The mechanism of inhibition of T cell proliferation. Transplantation. 1993 Jun; 55(6):1361-6.
Score: 0.078
-
Leflunomide, a novel immunomodulatory agent: in vitro analyses of the mechanism of immunosuppression. Transplant Proc. 1993 Feb; 25(1 Pt 1):747-9.
Score: 0.077
-
Toll-like receptor signaling in transplantation. Curr Opin Organ Transplant. 2008 Aug; 13(4):358-65.
Score: 0.056
-
Mechanistic study of malononitrileamide FK778 in cardiac transplantation and CMV infection in rats. Transplantation. 2005 Jan 15; 79(1):17-22.
Score: 0.044
-
Experiences with leflunomide in solid organ transplantation. Transplantation. 2002 Feb 15; 73(3):358-66.
Score: 0.036
-
Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection. Transplantation. 2001 May 27; 71(10):1385-9.
Score: 0.034
-
Combination of antilymphocyte globulin and leflunomide leads to superior grafts. Transplant Proc. 2001 Feb-Mar; 33(1-2):569.
Score: 0.033
-
Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide. Transplantation. 2001 Jan 15; 71(1):170-4.
Score: 0.033
-
Tolerance of T-independent xeno-antibody responses in the hamster-to-rat xenotransplantation model is species-restricted but not tissue-specific. Xenotransplantation. 2000 Feb; 7(1):48-57.
Score: 0.031
-
In vitro and in vivo antitumor activity of a novel immunomodulatory drug, leflunomide: mechanisms of action. Biochem Pharmacol. 1999 Nov 01; 58(9):1405-13.
Score: 0.031
-
In vivo activity of leflunomide: pharmacokinetic analyses and mechanism of immunosuppression. Transplantation. 1999 Jul 15; 68(1):100-9.
Score: 0.030
-
FK506 treatment in combination with leflunomide in hamster-to-rat heart and liver xenograft transplantation. Transplantation. 1998 Oct 15; 66(7):832-7.
Score: 0.028
-
Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation. Transplantation. 1998 Sep 27; 66(6):692-8.
Score: 0.028
-
Induction of species-specific host accommodation in the hamster-to-rat xenotransplantation model. J Immunol. 1998 Aug 15; 161(4):2044-51.
Score: 0.028
-
Differential effect of leflunomide on concordant xenogeneic islet graft rejection and recurrence of autoimmune diabetes. Transplant Proc. 1998 Mar; 30(2):463-4.
Score: 0.027
-
Leflunomide-based immunosuppression for porcine islet xenotransplantation. Transplant Proc. 1998 Mar; 30(2):515.
Score: 0.027
-
Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgG1 production. J Immunol. 1998 Feb 15; 160(4):1581-8.
Score: 0.027
-
Quantitation of the changes in splenic architecture during the rejection of cardiac allografts or xenografts. Transplantation. 1997 Aug 15; 64(3):448-53.
Score: 0.026
-
Effect of leflunomide and cyclosporine on concordant xenogeneic islet transplantation in streptozotocin-induced and autoimmune diabetic mice. Transplant Proc. 1997 Jun; 29(4):2155.
Score: 0.026
-
Successful xenotransplantation of adult porcine islets in NOD and BALB/c mice with leflunomide and cyclosporine. Transplant Proc. 1997 Jun; 29(4):2166-7.
Score: 0.026
-
Prolongation of rat islet allograft survival by the immunosuppressive agent leflunomide. Transplantation. 1997 Mar 15; 63(5):711-6.
Score: 0.025
-
In vivo effects of leflunomide on normal pancreatic islet and syngeneic islet graft function. Transplantation. 1997 Mar 15; 63(5):716-21.
Score: 0.025
-
Leflunomide, a potential immunosuppressant for pancreatic islet transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):1296-7.
Score: 0.025
-
Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation. Transplant Proc. 1996 Apr; 28(2):691-2.
Score: 0.024
-
Regulation of B cell function by the immunosuppressive agent leflunomide. Transplantation. 1996 Feb 27; 61(4):635-42.
Score: 0.024
-
Pharmacologically induced regression of chronic transplant rejection. Transplantation. 1995 Nov 27; 60(10):1065-72.
Score: 0.023
-
Leflunomide controls rejection in hamster to rat cardiac xenografts. Transplantation. 1994 Oct 15; 58(7):828-34.
Score: 0.022
-
Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts. Transplant Proc. 1994 Jun; 26(3):1263-5.
Score: 0.021
-
Leflunomide immunosuppression in rat small intestinal transplantation. Transplant Proc. 1994 Jun; 26(3):1599-600.
Score: 0.021
-
Immunosuppressive effects of leflunomide in a cardiac allograft model. Transplant Proc. 1993 Feb; 25(1 Pt 1):745-6.
Score: 0.019
-
Immunosuppression preventing concordant xenogeneic islet graft rejection is not sufficient to prevent recurrence of autoimmune diabetes in nonobese diabetic mice. Transplantation. 1998 May 27; 65(10):1310-4.
Score: 0.007
-
Splanchnic transplantation. Transplant Proc. 1994 Jun; 26(3):1411-2.
Score: 0.005